updat strateg focu
view partner ramp
commerci effort om ahead galactic-hf
interim readout posit addit agre
compani strateg plan priorit near-term spend
om
time-frame galactic-hf interim data narrow call
focus advanc cardiac muscl program specif
omecamtiv mecarbil om phase interim analysi expect vs
previous addit detail given upcom
phase studi call redwood-hcm addit stress
priorit cardiac program ahead skelet muscl program
indic alloc fund go forward
encourag find increment posit priorit
cardiac muscl program greater confid still believ
share remain rel range-bound near-term given limit
signific clinic catalyst omecamtiv mecarbil interim readout
takeaway phase studi enrol two sequenti cohort
patient random option enrol third cohort
patient receiv echocardiograph dose determin
need titrat receiv three escal dose
cytokinet astella tent agre yet bind revis
agreement retain exclus right commerci
fsta includ reldesemtiv astella would provid partial co-
fund phase trial al entitl low- mid-singl digit
royalti manag indic look re-partn drug
high convict could continu lead develop
manag base case galactic-hf continu past interim
analysi partner ramp commerci
prepar omecamtiv mecarbil studi stop earli
model updat lower expens estim revenu
partnership slightli manag reiter cash burn guidanc net
result ep chang
valuat equal-weight pt dcf model peak unadjust us
omecamtiv mecarbil sale
 unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
pt deriv dcf use
sale adjust revenu use probabl
success po om reldesemtiv al
reldesemtiv sma
greater market share bull case assum greater adopt
omecamtiv mecarbil reldesemtiv
om commerci begin base case assumpt
describ price target methodolog
product candid fail advanc unabl advanc
product candid trade cash value-per-share
equal-weight thesi base lack
signific clinic catalyst ahead
omecamtiv mecarbil phase data
cautiou reldesemtiv given data
sma al
efficaci galactic-hf
omecamtiv mecarbil phase data
risk achiev price
data omecamtiv mecarbil
stop interim overwhelmingli
posit efficaci faster-than-expect
advanc pipelin candid
phase data galactic-hf
termin earli futil follow
act financi advisor beigen ltd beigen relat
global strateg oncolog collabor inc announc
octob propos collabor subject approv beigen
sharehold regulatori approv customari close condit report
inform provid herein intend provid vote advic ii serv
endors propos transact iii result procur withhold
revoc proxi action secur holder pleas refer note
end report
act financi advisor bristol-my squibb compani bristol-
myer relat propos acquisit celgen corpor celgen
announc januari propos transact subject customari close
condit includ bristol-my celgen stockhold approv receipt
customari close condit regulatori approv report inform
provid herein intend provid vote advic ii serv endors
propos transact iii result procur withhold revoc
proxi action secur holder bristol-my agre pay fee
financi servic includ transact fee financ fee
conting upon consumm transact pleas refer note end
report act financi advisor bristol-my squibb
compani relat agreement celgen corpor celgen
inc would acquir global right
otezla apremilast announc august transact pursuant
merger agreement celgen propos transact subject
celgen enter consent decre feder trade commiss
connect pend merger close pend merger
satisfact customari close condit
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report jeffrey
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
www morganstanley com/institutional/research/conflictpolici portugues version polici found www morganstanley com br
import us regulatori disclosur subject compani
septemb benefici own class common equiti secur follow compani cover
within last month manag co-manag public offer offer secur alector inc
within last month receiv compens invest bank servic alector inc ascendi
next month expect receiv intend seek compens invest bank servic akebia
within last month receiv compens product servic invest bank servic amgen inc
within last month provid provid invest bank servic invest bank client relationship
follow compani alector inc amgen inc
within last month either provid provid non-invest bank securities-rel servic and/or past
enter agreement provid servic client relationship follow compani amgen inc beigen ltd biogen inc biomarin
 co llc make market secur alector inc
equiti research analyst strategist princip respons prepar research receiv compens base upon
variou factor includ qualiti research investor client feedback stock pick competit factor firm revenu overal invest bank
revenu equiti research analyst strategist compens link invest bank capit market transact perform morgan
stanley profit revenu particular trade desk
affili busi relat companies/instru cover research includ market make provid
liquid fund manag commerci bank extens credit invest servic invest bank sell buy
custom securities/instru compani cover research princip basi may posit debt
compani instrument discuss report trade may trade princip debt secur relat deriv
subject debt research report
certain disclosur list also complianc applic regul non-u jurisdict
use rel rate system use term overweight equal-weight not-rat underweight see definit morgan
stanley assign rate buy hold sell stock cover overweight equal-weight not-rat underweight equival
buy hold sell investor care read definit rate use morgan stanley research addit sinc morgan stanley research
contain complet inform concern analyst view investor care read morgan stanley research entireti infer
content rate alon case rate research use reli upon invest advic investor decis buy sell
stock depend individu circumst investor exist hold consider
octob
stock rate describ appli fundament equiti research appli debt research produc firm
disclosur purpos accord nasd nyse requir includ categori head buy hold sell alongsid
rate overweight equal-weight not-rat underweight assign rate buy hold sell stock cover
overweight equal-weight not-rat underweight equival buy hold sell repres recommend rel weight see
definit satisfi regulatori requir correspond overweight posit stock rate buy recommend correspond
equal-weight not-rat hold underweight sell recommend respect
data includ common stock adr current assign rate invest bank client compani receiv invest
bank compens last month due round decim percentag provid total column may add exactli
overweight stock total return expect exceed averag total return analyst industri industri team coverag univers
risk-adjust basi next month
equal-weight stock total return expect line averag total return analyst industri industri team coverag univers
risk-adjust basi next month
not-rat nr current analyst adequ convict stock total return rel averag total return analyst
industri industri team coverag univers risk-adjust basi next month
underweight stock total return expect averag total return analyst industri industri team coverag univers
risk-adjust basi next month
unless otherwis specifi time frame price target includ morgan stanley research month
attract analyst expect perform industri coverag univers next month attract vs relev broad
market benchmark indic
in-lin analyst expect perform industri coverag univers next month line relev broad market
benchmark indic
cautiou analyst view perform industri coverag univers next month caution vs relev broad market
benchmark indic
benchmark region follow north america latin america relev countri index latin america index europ
europ japan topix asia relev countri index sub-region index ac asia pacif ex japan index
stock price price target rate histori rate definit
import disclosur morgan stanley smith barney llc custom
